Search research articles
Contact Us
Filters
Showing results (271-280 of 504) with videos related to
Page
of 51
Sort By:
Cancer Research
|
July 23, 2003
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers
Jiuhong Yuan, Robert Z Luo, Satoshi Fujii, et al.
British Journal of Haematology
|
November 22, 2007
ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms
Junya Kuroda, Shinya Kimura, Michael Andreeff, et al.
Oncotarget
|
December 20, 2017
Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities
Xiao Huang, Mengru Cao, Shuhong Wu, et al.
British Journal of Haematology
|
October 3, 2002
Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome
Naoto T Ueno, Athanasios Anagnostopoulos, Gabriela Rondón, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia
Francis Giles, Deborah Thomas, Guillermo Garcia-Manero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia
Ettore Biagi, Raphael Rousseau, Eric Yvon, et al.
Blood Advances
|
November 22, 2019
LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML
Neil Beeharry, Sean Landrette, Sophia Gayle, et al.
Haematologica
|
October 13, 2022
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
Weiguo Zhang, Guopan Yu, Hongying Zhang, et al.
Blood Neoplasia
|
August 4, 2025
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, et al.
Cell Reports. Medicine
|
May 11, 2024
Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice
Rasoul Pourebrahim, Rafael Heinz Montoya, Hiroki Akiyama, et al.
Page
of 51
Search research articles
Search
Showing results (271-280 of 504) with videos related to
Sort By:
Page
of 51
Cancer Research
|
July 23, 2003
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers
Jiuhong Yuan, Robert Z Luo, Satoshi Fujii, et al.
British Journal of Haematology
|
November 22, 2007
ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms
Junya Kuroda, Shinya Kimura, Michael Andreeff, et al.
Oncotarget
|
December 20, 2017
Anti-leukemia activity of NSC-743380 in SULT1A1-expressing acute myeloid leukemia cells is associated with inhibitions of cFLIP expression and PI3K/AKT/mTOR activities
Xiao Huang, Mengru Cao, Shuhong Wu, et al.
British Journal of Haematology
|
October 3, 2002
Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome
Naoto T Ueno, Athanasios Anagnostopoulos, Gabriela Rondón, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2004
A Phase I and pharmacokinetic study of VNP40101M, a novel sulfonylhydrazine alkylating agent, in patients with refractory leukemia
Francis Giles, Deborah Thomas, Guillermo Garcia-Manero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia
Ettore Biagi, Raphael Rousseau, Eric Yvon, et al.
Blood Advances
|
November 22, 2019
LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AML
Neil Beeharry, Sean Landrette, Sophia Gayle, et al.
Haematologica
|
October 13, 2022
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
Weiguo Zhang, Guopan Yu, Hongying Zhang, et al.
Blood Neoplasia
|
August 4, 2025
PPARγ-induced upregulation of fatty acid metabolism confers resistance to venetoclax and decitabine therapy in AML
Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, et al.
Cell Reports. Medicine
|
May 11, 2024
Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult mice
Rasoul Pourebrahim, Rafael Heinz Montoya, Hiroki Akiyama, et al.
Page
of 51